GIP increases insulin receptor affinity and cellular sensitivity in adipocytes

Area of Science:

• Endocrinology
• Metabolic Research
• Molecular Pharmacology

Background:

• Glucose ingestion enhances insulin receptor affinity and target tissue sensitivity.
• Gastrointestinal hormones play a role in metabolic regulation.

Purpose of the Study:

• To investigate if gastric inhibitory polypeptide (GIP) can mimic the effects of glucose on insulin action.
• To determine the direct impact of GIP on insulin receptor binding and cellular glucose uptake.

Main Methods:

• In vitro incubation of rat adipocytes with varying concentrations of GIP.
• Assessment of insulin receptor binding affinity using binding isotherms.
• Measurement of insulin-mediated glucose uptake at low insulin concentrations.

Main Results:

• GIP significantly increased insulin receptor affinity in adipocytes.
• GIP potentiated insulin-stimulated glucose uptake, particularly at low insulin levels.
• Cholecystokinin did not affect insulin receptor binding or glucose uptake.

Conclusions:

• Gastric inhibitory polypeptide (GIP) directly enhances insulin receptor affinity and cellular sensitivity to insulin.
• GIP may play a dual role in glucose metabolism by stimulating insulin secretion and modulating insulin action.
• These findings suggest GIP as a potential therapeutic target for improving insulin sensitivity.